|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0018674,
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0034665,
umls-concept:C0035648,
umls-concept:C0041909,
umls-concept:C0199176,
umls-concept:C0439064,
umls-concept:C1257890,
umls-concept:C1527148,
umls-concept:C2603343
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1994-1-7
|
|
pubmed:abstractText |
To evaluate the impact of risk factors on the development of stress-related upper gastrointestinal bleeding in severe head injury patients randomized to treatment with a 6.25 mg/hr continuous ranitidine infusion or placebo.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0090-3493
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1844-9
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:8252888-Adult,
pubmed-meshheading:8252888-Craniocerebral Trauma,
pubmed-meshheading:8252888-Cross Infection,
pubmed-meshheading:8252888-Double-Blind Method,
pubmed-meshheading:8252888-Female,
pubmed-meshheading:8252888-Gastrointestinal Hemorrhage,
pubmed-meshheading:8252888-Glasgow Coma Scale,
pubmed-meshheading:8252888-Humans,
pubmed-meshheading:8252888-Incidence,
pubmed-meshheading:8252888-Infusions, Intravenous,
pubmed-meshheading:8252888-Male,
pubmed-meshheading:8252888-Pneumonia,
pubmed-meshheading:8252888-Prospective Studies,
pubmed-meshheading:8252888-Ranitidine,
pubmed-meshheading:8252888-Respiration, Artificial,
pubmed-meshheading:8252888-Risk Factors,
pubmed-meshheading:8252888-Stress, Physiological
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. The Ranitidine Head Injury Study Group.
|
|
pubmed:affiliation |
Glaxo Pharmaceuticals, Research Triangle Park, NC 27709.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
